These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 33878119

  • 1. Evaluation of drug-resistant tuberculosis treatment outcome in Portugal, 2000-2016.
    Oliveira O, Gaio R, Correia-Neves M, Rito T, Duarte R.
    PLoS One; 2021; 16(4):e0250028. PubMed ID: 33878119
    [Abstract] [Full Text] [Related]

  • 2. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
    Alene KA, Yi H, Viney K, McBryde ES, Yang K, Bai L, Gray DJ, Clements ACA, Xu Z.
    BMC Infect Dis; 2017 Aug 16; 17(1):573. PubMed ID: 28814276
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.
    Clin Infect Dis; 2008 Aug 15; 47(4):496-502. PubMed ID: 18611154
    [Abstract] [Full Text] [Related]

  • 5. Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China.
    He XC, Tao NN, Liu Y, Zhang XX, Li HC.
    BMC Infect Dis; 2017 Aug 09; 17(1):555. PubMed ID: 28793873
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Guglielmetti L, Veziris N, Aubry A, Brossier F, Bernard C, Sougakoff W, Jarlier V, Robert J.
    Int J Tuberc Lung Dis; 2018 Jan 01; 22(1):54-59. PubMed ID: 29297426
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
    Shah NS, Pratt R, Armstrong L, Robison V, Castro KG, Cegielski JP.
    JAMA; 2008 Nov 12; 300(18):2153-60. PubMed ID: 19001626
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference?
    Balabanova Y, Ignatyeva O, Fiebig L, Riekstina V, Danilovits M, Jaama K, Davidaviciene E, Radiulyte B, Popa CM, Nikolayevskyy V, Drobniewski F.
    Thorax; 2016 Sep 12; 71(9):854-61. PubMed ID: 27012887
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
    Gandhi NR, Andrews JR, Brust JC, Montreuil R, Weissman D, Heo M, Moll AP, Friedland GH, Shah NS.
    Int J Tuberc Lung Dis; 2012 Jan 12; 16(1):90-7. PubMed ID: 22236852
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence, associated factors, outcomes and transmission of extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in São Paulo, Brazil: a cross-sectional study.
    Gallo JF, Pinhata JMW, Simonsen V, Galesi VMN, Ferrazoli L, Oliveira RS.
    Clin Microbiol Infect; 2018 Aug 12; 24(8):889-895. PubMed ID: 29175351
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
    Ei PW, Aung WW, Nyunt WW, Swe TL, Htwe MM, Win SM, Aung ST, Chang CL, Lee HY, Lee JS.
    Int J Tuberc Lung Dis; 2018 Jan 01; 22(1):47-53. PubMed ID: 29297425
    [Abstract] [Full Text] [Related]

  • 18. Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
    Kempker RR, Kipiani M, Mirtskhulava V, Tukvadze N, Magee MJ, Blumberg HM.
    Emerg Infect Dis; 2015 Jun 01; 21(6):992-1001. PubMed ID: 25993036
    [Abstract] [Full Text] [Related]

  • 19. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007.
    Marks SM, Flood J, Seaworth B, Hirsch-Moverman Y, Armstrong L, Mase S, Salcedo K, Oh P, Graviss EA, Colson PW, Armitige L, Revuelta M, Sheeran K, TB Epidemiologic Studies Consortium.
    Emerg Infect Dis; 2014 May 01; 20(5):812-21. PubMed ID: 24751166
    [Abstract] [Full Text] [Related]

  • 20. Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience.
    Liu CH, Li L, Chen Z, Wang Q, Hu YL, Zhu B, Woo PC.
    PLoS One; 2011 Apr 29; 6(4):e19399. PubMed ID: 21559362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.